within Pharmacolibrary.Drugs.N_NervousSystem.N05B_Anxiolytics.N05BA04_Oxazepam;

model Oxazepam
  extends Pharmacolibrary.Drugs.ATC.N.N05BA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N05BA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxazepam is a benzodiazepine medication used primarily for the management of anxiety disorders, alcohol withdrawal symptoms, and for its sedative properties. Oxazepam acts on the central nervous system, producing anxiolytic, sedative, and muscle relaxant effects. It is approved and still used today, particularly favored due to its intermediate half-life and lack of active metabolites.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (both sexes, ages 20-40 years) after single oral administration.</p><h4>References</h4><ol><li><p>Vinkers, CH, et al., &amp; Vis, R (2012). [Choosing the correct benzodiazepine: mechanism of action and pharmacokinetics]. <i>Nederlands tijdschrift voor geneeskunde</i> 155(35) A4900–None. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22929751/\">https://pubmed.ncbi.nlm.nih.gov/22929751</a></p></li><li><p>Sonne, J, et al., &amp; Andreasen, F (1991). Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects. <i>British journal of clinical pharmacology</i> 31(6) 719–722. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1991.tb05602.x\">10.1111/j.1365-2125.1991.tb05602.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1867967/\">https://pubmed.ncbi.nlm.nih.gov/1867967</a></p></li><li><p>Greenblatt, DJ (1981). Clinical pharmacokinetics of oxazepam and lorazepam. <i>Clinical pharmacokinetics</i> 6(2) 89–105. DOI:<a href=\"https://doi.org/10.2165/00003088-198106020-00001\">10.2165/00003088-198106020-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6111408/\">https://pubmed.ncbi.nlm.nih.gov/6111408</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Oxazepam;
